Lapsed Sep 1, 2017 on the fee record · High confidence
20-year base term ended Nov 14, 2025
Second maintenance fee unpaid; grace period ended.
Held by Windtree Therapeutics, Inc.
Filed Nov 14, 2005 as application 11/274,701 · Granted Sep 1, 2009
Base term, 20 years from filing
Today
Lapsed Sep 1, 2017
2005
2026
Clock starts
Nov 14, 2005
Nov 14, 2005
No longer in force
Sep 1, 2017
Sep 1, 2017
Granted
Sep 1, 2009
Sep 1, 2009
Term would have run to
Nov 14, 2025
Nov 14, 2025
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Nov 14, 2025: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 14, 2005, when this application, 11/274,701, was filed | Nov 14, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed Sep 1, 2017 | High confidence |
| Computed term end | The steps above, in order | Sep 1, 2017 | High confidence |
This family
| US 7,582,312 | this patent Sep 2017 | Sep 2017 |
| Application PCT/US2005/041281 | PCT application no patent term | no patent term |
| US 8,337,815 | Lapsed on the fee record Dec 2016 | Dec 2016 |
| Application PCT/US2005/046862 | PCT application no patent term | no patent term |
| US 7,541,331 | Term ended Jan 2026 | Jan 2026 |
| US 8,221,772 | In force Sep 2027 | Sep 2027 |
| Application PCT/US2013/039592 | PCT application no patent term | no patent term |
| US 8,748,396 | In force Mar 2033 | Mar 2033 |
8 of 14 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 10, 2006 Reel 17608, frame 578 | Johnson, Mark; Coe, Roy | Discover Laboratories | Assignment of Assignor's Interest |
| Nov 2, 2006 Reel 18468, frame 530 | Discovery Laboratories, Inc. | Pharmabio Development Inc. | Security Agreement |
| May 31, 2007 Reel 19362, frame 608 | Discovery Laboratories, Inc. | Merrill Lynch Capital | Security Agreement |
| Jan 4, 2012 Reel 27478, frame 256 | Pharmabio Development Inc. | Discovery Laboratories, Inc. | Release of Security Interest |
| Jan 24, 2012 Reel 27585, frame 653 | GE Business Financial Services, Inc. | Discovery Laboratories, Inc. | Release of Security Interest |
| May 4, 2016 Reel 38606, frame 468 | Discovery Laboratories, Inc. | Windtree Therapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
5
later US patents cite this one
That is below the median of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.